| abstract |
Compounds of Formula I, as shown below and defined herein: n n n n n n n n n n and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK). |